MAIA Biotechnology, Inc.MAIANYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+15.6%
5Y CAGR+29.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+15.6%/yr
Annual compound
5Y CAGR
+29.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.96M | +47.2% |
| 2024 | $16.96M | -16.0% |
| 2023 | $20.18M | +24.8% |
| 2022 | $16.18M | +107.7% |
| 2021 | $7.79M | +11.6% |
| 2020 | $6.98M | +0.8% |
| 2019 | $6.92M | - |